Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting

ConclusionsA substantial percentage of biologic-na ïve IBD patients suffers from active disease/steroid dependency. The majority receives a monotherapy with systemic CS. Referral to gastroenterologists for treatment optimization is recommended, also because active disease/steroid dependency is associated with increased HCRU/cost.

http://link.springer.com/10.1007/s00384-020-03588-w

Source: International Journal of Colorectal Disease - May 17, 2020 Category: Gastroenterology Source Type: research